Jan. 30, 2026: State Advocacy Update

| 1 Min Read

Specific actions policymakers can take to end the nation’s drug overdose epidemic

A new AMA issue brief (PDF) details seven specific ways medical societies can help end the nation’s overdose epidemic: 

Haven't subscribed?

Stay current on the latest on the issues impacting physicians, patients and the healthcare environment with the AMA’s Advocacy Update newsletter.

  • Remove restrictions on buprenorphine and protect individuals with a substance use disorder. 

  • Take action to enforce mental health and substance use disorder parity. 

  • Take steps to address increasing harms from cannabis. 

  • Support public health legislation to regulate kratom and tianeptine. 

  • Increase access to naloxone and other evidence-based prevention efforts. 

  • Help patients with pain. 

  • Ensure opioid litigation settlement dollars go to evidence-based efforts. 

Each recommendation is backed with detailed policy recommendations. For example, given that one of the ongoing barriers to buprenorphine is a misguided reliance on dosage thresholds, the issue brief provides resources and citations for state legislative examples. The issue brief also identifies best legislative and regulatory practices as well as identifying where AMA has model legislation or other resources to support state advocacy. 

Your Powerful Ally

Through AMA advocacy and policymaking, we are addressing the issues important to you—together—and shaping what’s next for physicians.

FEATURED STORIES

Willie Underwood III, MD, inaugural address at the 2026 Annual Meeting of the HOD

New AMA president: Courageous leadership can reshape healthcare

| 5 Min Read
2026 Annual Meeting of the HOD

AMA adds more to its game plan to fix prior authorization

| 6 Min Read
AMA Annual Meeting Reference Committee in session

AMA: No, physicians are not “providers”

| 5 Min Read
Reference Committee at the 2024 Annual Meeting of the HOD

With AI increasingly part of care, transparency and quality are musts

| 6 Min Read